Radar > 353025

Blau plans to start implementing new factory at Suape Port Industrial Complex, in Pernambuco, in 2022

Blau planeja iniciar implantação de nova fábrica no Complexo Industrial Portuário de Suape, em Pernambuco, em 2022

Intel ID : 353025

Intel ID 353025
Value EUR 186,38m
Native Currency Brazilian Real (BRL)
Exchange Rate:
Financial Data - Blau Farmacêutica
(31 Dec 2023)
Revenue: -
EBITDA: -
Date
Country
Geography
Subsector (Old TTR Sectors)
Primary Subsector (TTRSC)
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution (Primary)
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Secondary Subsectors (TTRSC)
30.01.01 Biopharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

30.01.04 Specialty Pharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

30.02.03 Healthcare Product Distributors
30 Healthcare / 30.02 Healthcare Equipment & Supplies

15.05.08 Food & Beverage Retail
15 Consumer Products & Services / 15.05 Distribution & Retail

Type
Intel Grade
Source
Tags

Bidder

Name
verified
Subsector (Old TTR Sectors)
Industry / Pharmaceutical, Parapharmaceutical and Cosmetics (Primary)
Primary Sector (TTRSC)
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Secondary Sectors (TTRSC)
15.05.08 Food & Beverage Retail
15 Consumer Products & Services / 15.05 Distribution & Retail

30.01.01 Biopharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

30.01.04 Specialty Pharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

30.02.03 Healthcare Product Distributors
30 Healthcare / 30.02 Healthcare Equipment & Supplies

Country
Website
Description

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.